USA flag logo/image

An Official Website of the United States Government

Circulating Prostate Cancer Progenitor Cell Assay Development

Award Information

Agency:
Department of Defense
Branch:
Army
Award ID:
Program Year/Program:
2011 / STTR
Agency Tracking Number:
A2-4144
Solicitation Year:
2008
Solicitation Topic Code:
A08-T041
Solicitation Number:
2008.A
Small Business Information
ANDROBIOSYS, INC.
875 Ellicott St BUFFALO, NY 14203-1070
View profile »
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
 
Phase 2
Fiscal Year: 2011
Title: Circulating Prostate Cancer Progenitor Cell Assay Development
Agency / Branch: DOD / ARMY
Contract: W81XWH-08-C-0099
Award Amount: $747,553.00
 

Abstract:

The technical objectives of this Phase II project are to identify unique biomarkers and produce molecular, antibody and peptide reagents that are specific for human prostate cancer progenitor stem cells. We propose to utilize the information from the Phase I award and subsequent research to develop assay reagents that would be used to develop a blood-based assay specific for circulating prostate cancer stem cells. This assay should prove to be an informative prognostic tool for predicting aggressiveness and metastatic potential of prostate cancer.

Principal Investigator:

Michael G. Zwick
CEO
(716) 860-7920
mzwick@androbiosys.com

Business Contact:

Michael G. Zwick
CEO
(716) 860-7920
mzwick@androbiosys.com
Small Business Information at Submission:

AndroBioSys, Inc.
73 High Street Buffalo, NY 14203-1149

EIN/Tax ID: 202315778
DUNS: N/A
Number of Employees:
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: Yes
Research Institution Information:
Roswell Park Cancer Institute
Elm and Carlton Streets
Buffalo, NY 14263-
Contact: John T. Blandino
Contact Phone: (716) 845-2312